microsphere beads (DiaSorin Biotechnology)
Structured Review
Microsphere Beads, supplied by DiaSorin Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 132 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/verification/Calibration+solution/pmc04737983-121-0-3
Average 94 stars, based on 132 article reviews
Images
Related Articles
Generated:Article Title: pLDH to identify severity in imported malaria: Implementing smartphone video analysis for rapid clinical decision-making. Article Snippet: .. In order to quantify the levels of PfHRP2 and PfLDH, a Software:Article Title: Screening for novel variable domains of the heavy chains of heavy-chain antibodies targeting different epitopes of thrombomodulin and Luminex fluorescence immunoassay for soluble thrombomodulin. Article Snippet: Venous thromboembolism (VTE), a potentially fatal disease, poses considerable health risks that should not be overlooked.. Early disease screening and timely intervention with anticoagulant drugs are crucial for its management.. However, effective screening methods, real-time anticoagulant efficacy monitoring approaches, and high-performance diagnostic antibodies are currently lacking for VTE. Enzyme-linked Immunosorbent Assay:Article Title: Transforming cytokine diagnostics: AI, multiplexing, and point-of-care biosensing technologies. Article Snippet: Cytokines are central regulators of immune responses and have emerged as key biomarkers in diverse pathological conditions, including infections, autoimmune disorders, and cancer.. Conventional laboratory methods for cytokine detection, while accurate, often lack the speed, portability, and multiplexing capacity required for timely clinical decision-making.. Recent advances in biosensor technology—particularly at the point-of-care (POC)—are reshaping this landscape by enabling rapid, decentralized, and sensitive detection of cytokine panels in complex biological samples. Inhibition:Article Title: IL-10 muteins and fusion proteins thereof Article Snippet: .. TABLE 5 Receptor-ligand inhibition for select TREM1 antibodies Receptor-ligand Antibody ID % inhibition 3E12 101% 34D1 101% 30H2 101% 44A5 100% 46H7 100% 49A2 100% 50A12 100% 57C10 100% 57F5 100% 61B12 87% 61G5 91% 63F8 93% 64D7 96% 66B8 85% TREM-1 Antibody Relative Affinity Ranking by Limiting Antigen Assay: TREM1 hybridoma supernatants were affinity-ranked within the panel by their binding kinetics to soluble TREM-1 in a limiting antigen assay using Antigen Assay:Article Title: IL-10 muteins and fusion proteins thereof Article Snippet: .. TABLE 5 Receptor-ligand inhibition for select TREM1 antibodies Receptor-ligand Antibody ID % inhibition 3E12 101% 34D1 101% 30H2 101% 44A5 100% 46H7 100% 49A2 100% 50A12 100% 57C10 100% 57F5 100% 61B12 87% 61G5 91% 63F8 93% 64D7 96% 66B8 85% TREM-1 Antibody Relative Affinity Ranking by Limiting Antigen Assay: TREM1 hybridoma supernatants were affinity-ranked within the panel by their binding kinetics to soluble TREM-1 in a limiting antigen assay using Binding Assay:Article Title: IL-10 muteins and fusion proteins thereof Article Snippet: .. TABLE 5 Receptor-ligand inhibition for select TREM1 antibodies Receptor-ligand Antibody ID % inhibition 3E12 101% 34D1 101% 30H2 101% 44A5 100% 46H7 100% 49A2 100% 50A12 100% 57C10 100% 57F5 100% 61B12 87% 61G5 91% 63F8 93% 64D7 96% 66B8 85% TREM-1 Antibody Relative Affinity Ranking by Limiting Antigen Assay: TREM1 hybridoma supernatants were affinity-ranked within the panel by their binding kinetics to soluble TREM-1 in a limiting antigen assay using FACS:Article Title: IL-10 muteins and fusion proteins thereof Article Snippet: .. TABLE 5 Receptor-ligand inhibition for select TREM1 antibodies Receptor-ligand Antibody ID % inhibition 3E12 101% 34D1 101% 30H2 101% 44A5 100% 46H7 100% 49A2 100% 50A12 100% 57C10 100% 57F5 100% 61B12 87% 61G5 91% 63F8 93% 64D7 96% 66B8 85% TREM-1 Antibody Relative Affinity Ranking by Limiting Antigen Assay: TREM1 hybridoma supernatants were affinity-ranked within the panel by their binding kinetics to soluble TREM-1 in a limiting antigen assay using |
